跳至主要内容
临床试验/NL-OMON29324
NL-OMON29324招募中不适用

ew Influenza A (H1N1) disease incidence and immunogenicity of the pandemic influenza A (H1N1) vaccin in healthy adults.

etherlands Vaccin Institute0 个研究点目标入组 375 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
375

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Good self-reported health according to the investigator;
  • 2. Willingness and ability to adhere to the study regimen;

排除标准

  • The exclusion criteria with regard to contra-indications for receiving the pandemic influenza vaccine are:
  • 1. Allergy to any of the components of the vaccine or trace residues of eggs, chicken proteins, kanamycin and neomycin sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB).

研究者

发起方
etherlands Vaccin Institute

相似试验